Biology
Endothelial Glycocalyx Degradation in Sepsis
Quick fact
The endothelial glycocalyx is only about 0.5 to 3 micrometers thick, yet it holds your entire blood volume in place. In sepsis, it can be destroyed within hours, leading to massive fluid leakage into tissues.
Why this is interesting
Every blood vessel in your body is lined by a delicate sugar coating that keeps you alive. What happens when your immune system—meant to save you—strips that coating away during a severe infection?
Read the full explanation
Understanding Endothelial Glycocalyx Degradation in Sepsis
To understand this, picture a riverbed. The endothelial cells are the banks, and the glycocalyx is a thick, gel-like layer of sugar and protein molecules that covers the banks, touching the water. It acts like a filter and a barrier. Normally, it keeps large molecules (like albumin) inside the river (the blood vessel), and it also senses blood flow. It's a vital protective coat. In sepsis, bacteria or other pathogens trigger an overwhelming immune response. This response is like a huge storm that releases destructive enzymes (such as matrix metalloproteinases) and reactive oxygen species. These act like chemical scissors that snip the glycocalyx away. Once the protective layer is gone, the vessel walls become 'leaky'—water and proteins escape into the tissues, causing swelling (edema). This also impairs blood flow to organs, leading to oxygen shortage and ultimately organ failure.
A deeper explanation
The degradation is not a passive side effect but a key driver of sepsis pathology. The glycocalyx is composed of proteoglycans (e.g., syndecan-1) and glycosaminoglycans (e.g., heparan sulfate). Inflammatory mediators like TNF-α and IL-1β activate enzymes that cleave these components. Fragments of the glycocalyx then circulate in the blood, acting as damage-associated molecular patterns (DAMPs) that amplify inflammation further. The loss of the glycocalyx also exposes adhesion molecules on endothelial cells (like ICAM-1), leading to white blood cell sticking and clotting activation. This contributes to microthrombosis, tissue ischemia, and vascular leakage. Importantly, this understanding has therapeutic implications: strategies to protect or refill the glycocalyx (e.g., with corticosteroids, antithrombin, or specific enzyme inhibitors) are being explored. Thus, the glycocalyx is not just a passive victim; it's a central player in the progression of sepsis to severe dysfunction.